AT362510B - Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen - Google Patents
Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formenInfo
- Publication number
- AT362510B AT362510B AT767976A AT767976A AT362510B AT 362510 B AT362510 B AT 362510B AT 767976 A AT767976 A AT 767976A AT 767976 A AT767976 A AT 767976A AT 362510 B AT362510 B AT 362510B
- Authority
- AT
- Austria
- Prior art keywords
- dispersions
- peptide
- acid derivatives
- solid solutions
- hydrated forms
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000007962 solid dispersion Substances 0.000 title 1
- 239000006104 solid solution Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2546577A DE2546577B2 (de) | 1975-10-17 | 1975-10-17 | Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ATA767976A ATA767976A (de) | 1980-10-15 |
| AT362510B true AT362510B (de) | 1981-05-25 |
Family
ID=5959411
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT767976A AT362510B (de) | 1975-10-17 | 1976-10-15 | Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5854122B2 (member.php) |
| AT (1) | AT362510B (member.php) |
| AU (1) | AU508628B2 (member.php) |
| BE (1) | BE847368A (member.php) |
| CA (1) | CA1079641A (member.php) |
| CH (1) | CH643737A5 (member.php) |
| CS (1) | CS199647B2 (member.php) |
| DE (1) | DE2546577B2 (member.php) |
| DK (1) | DK146194C (member.php) |
| ES (1) | ES452420A1 (member.php) |
| FI (1) | FI762875A7 (member.php) |
| FR (1) | FR2327764A1 (member.php) |
| GB (1) | GB1560406A (member.php) |
| GR (1) | GR61268B (member.php) |
| HK (1) | HK3183A (member.php) |
| HU (1) | HU172533B (member.php) |
| IE (1) | IE43778B1 (member.php) |
| IL (1) | IL50686A (member.php) |
| MY (1) | MY8400063A (member.php) |
| NL (1) | NL184558C (member.php) |
| NO (1) | NO144468C (member.php) |
| NZ (1) | NZ182341A (member.php) |
| PH (1) | PH14513A (member.php) |
| PT (1) | PT65719B (member.php) |
| SE (1) | SE430379B (member.php) |
| SG (1) | SG63082G (member.php) |
| SU (1) | SU1165223A3 (member.php) |
| ZA (1) | ZA766166B (member.php) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1572226A (en) * | 1977-11-03 | 1980-07-30 | Hoechst Uk Ltd | Pharmaceutical preparations in solid unit dosage form |
| US4411882A (en) | 1978-12-21 | 1983-10-25 | Sandoz Ltd. | Galenical compositions |
| WO1980001242A1 (fr) * | 1978-12-21 | 1980-06-26 | Sandoz Ag | Preparations galeniques |
| FR2454804B1 (fr) * | 1979-04-26 | 1986-11-21 | Sanofi Sa | Medicament a base de dihydroergotoxine et son procede de preparation |
| US4366145A (en) * | 1981-06-24 | 1982-12-28 | Sandoz, Inc. | Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation |
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| HU198844B (en) * | 1984-06-14 | 1989-12-28 | Sandoz Ag | Process for producing new galenic pharmaceutical composition ensuring retarded release of active ingredient |
| ES2039287T3 (es) * | 1987-01-14 | 1993-09-16 | Ciba-Geigy Ag | Procedimiento para la obtencion de un sistema terapeutico peroral para productos activos dificilmente solubles. |
| FR2610827B1 (fr) * | 1987-02-18 | 1991-09-13 | Pf Medicament | Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication |
| US5064656A (en) * | 1989-11-14 | 1991-11-12 | Dr. Gergely & Co. | Uncoated pharmaceutical reaction tablet |
| DE4401646A1 (de) * | 1994-01-21 | 1995-07-27 | Krewel Werke Gmbh | Optimal freisetzende Kava-Extrakte |
| US6524832B1 (en) | 1994-02-04 | 2003-02-25 | Arch Development Corporation | DNA damaging agents in combination with tyrosine kinase inhibitors |
| US6632455B2 (en) | 1997-12-22 | 2003-10-14 | Schering Corporation | Molecular dispersion composition with enhanced bioavailability |
| IL136460A0 (en) * | 1997-12-22 | 2001-06-14 | Schering Corp | Molecular dispersion composition with enhanced bioavailability |
| US6316462B1 (en) | 1999-04-09 | 2001-11-13 | Schering Corporation | Methods of inducing cancer cell death and tumor regression |
| JP4965784B2 (ja) * | 1999-12-03 | 2012-07-04 | ポリケム・ソシエテ・アノニム | バイオアベイラビリティの向上した麦角アルカロイドの徐放性医薬組成物の製造法及びその組成物 |
| US7771746B2 (en) | 1999-12-03 | 2010-08-10 | Polichem Sa | Methods for making sustained-release pharmaceutical compositions of ergot alkaloids having improved bioavailability and compositions thereof |
| US7135436B2 (en) | 2003-05-05 | 2006-11-14 | J.F. Daley International, Ltd. | Solid algicide, preparation and usage in recirculating water |
| US20060141038A1 (en) * | 2003-06-27 | 2006-06-29 | Bioprogress S. P. A. | Composite product obtainable by cogrinding of a active principle with a copolymer n-vinyl-2 pyrrolidone/vinyl-acetate |
| WO2016198983A1 (en) | 2015-06-09 | 2016-12-15 | Bend Research Inc. | Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules |
| KR102882996B1 (ko) * | 2025-04-07 | 2025-11-07 | (주)휴마스 | 액체크로마토그래피와 막전도도 측정모듈 및 개량된 uv산화반응기를 이용하는 분획된 수중 탄소 및 질소 측정장치 및 이를 이용한 측정방법 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1175430A (en) * | 1966-04-07 | 1969-12-23 | Sandoz Ltd | Pharmaceutical Compositions containing Ergot Alkaloids |
-
1975
- 1975-10-17 DE DE2546577A patent/DE2546577B2/de not_active Withdrawn
-
1976
- 1976-10-01 CH CH1244876A patent/CH643737A5/de not_active IP Right Cessation
- 1976-10-08 DK DK454176A patent/DK146194C/da not_active IP Right Cessation
- 1976-10-08 SE SE7611189A patent/SE430379B/xx not_active IP Right Cessation
- 1976-10-08 NO NO763446A patent/NO144468C/no unknown
- 1976-10-08 FI FI762875A patent/FI762875A7/fi not_active Application Discontinuation
- 1976-10-13 NL NLAANVRAGE7611295,A patent/NL184558C/xx not_active IP Right Cessation
- 1976-10-14 PH PH19008A patent/PH14513A/en unknown
- 1976-10-14 CA CA263,423A patent/CA1079641A/en not_active Expired
- 1976-10-14 FR FR7630866A patent/FR2327764A1/fr active Granted
- 1976-10-15 PT PT65719A patent/PT65719B/pt unknown
- 1976-10-15 HU HU76SA00002985A patent/HU172533B/hu not_active IP Right Cessation
- 1976-10-15 AU AU18754/76A patent/AU508628B2/en not_active Expired
- 1976-10-15 ES ES452420A patent/ES452420A1/es not_active Expired
- 1976-10-15 AT AT767976A patent/AT362510B/de not_active IP Right Cessation
- 1976-10-15 BE BE171578A patent/BE847368A/xx not_active IP Right Cessation
- 1976-10-15 ZA ZA00766166A patent/ZA766166B/xx unknown
- 1976-10-15 IE IE2282/76A patent/IE43778B1/en not_active IP Right Cessation
- 1976-10-15 NZ NZ182341A patent/NZ182341A/xx unknown
- 1976-10-15 GB GB42907/76A patent/GB1560406A/en not_active Expired
- 1976-10-15 SU SU762412401A patent/SU1165223A3/ru active
- 1976-10-15 IL IL50686A patent/IL50686A/xx unknown
- 1976-10-15 CS CS766685A patent/CS199647B2/cs unknown
- 1976-10-16 GR GR51952A patent/GR61268B/el unknown
- 1976-10-16 JP JP51123463A patent/JPS5854122B2/ja not_active Expired
-
1982
- 1982-12-23 SG SG630/82A patent/SG63082G/en unknown
-
1983
- 1983-01-20 HK HK31/83A patent/HK3183A/xx unknown
-
1984
- 1984-12-30 MY MY63/84A patent/MY8400063A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AT362510B (de) | Verfahren zur herstellung von festen loesungen oder dispersionen von peptidartigen lyserg- saeurederivaten oder deren hydrierten formen | |
| AT340895B (de) | Verfahren zur herstellung von neuen p-trifluormethylacylophenon-o- (2-aminoathyl) -oximathern und deren saureadditionssalzen | |
| AT344683B (de) | Verfahren zur herstellung von neuen substituierten 3-phenoxy-2-hydroxy-1-aminopropanen und deren saeureadditionssalzen | |
| AT352709B (de) | Verfahren zur herstellung von neuen benzothio- phenderivaten und von deren saeureadditions- salzen | |
| AT358555B (de) | Verfahren zur herstellung von neuen n-amino- alkyl-2-methoxy-benzolsulfonamiden sowie deren saeureadditionssalzen | |
| AT355563B (de) | Verfahren zur herstellung von neuen imidazolyl- oximaethern und von deren saeureadditionssalzen | |
| AT347034B (de) | Verfahren zur herstellung von neuen n- acylamino-alfa-arylacetamido-cephalosporinen sowie von deren salzen | |
| AT340389B (de) | Verfahren zur herstellung von 1-cyanophenoxy-2-hydroxy-3-aminopropanen sowie deren saureadditionssalzen | |
| AT346303B (de) | Verfahren zur herstellung von neuen 7- aminobenzocycloheptenen und deren saeure- additionssalzen | |
| AT344726B (de) | Verfahren zur herstellung von neuen 9-substituierten adeninen und deren saeureadditionssalzen | |
| ATA473076A (de) | Verfahren zur herstellung von neuen substituierten 3-aminomethylbenzolsulfonamiden sowie deren saureadditionssalzen | |
| ATA842675A (de) | Verfahren zur herstellung von neuenpyrrolidonderivaten sowie deren salzen | |
| AT340896B (de) | Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT338762B (de) | Verfahren zur herstellung von neuen substituierten basischen phenolathern sowie deren saureadditionssalzen | |
| AT340897B (de) | Verfahren zur herstellung von neuen p-methylthioacylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| ATA268375A (de) | Verfahren zur herstellung von 1-aryloxy-2-hydroxy-3-beta-(p-aminocarbonylphenyloxy)-athylaminopropanen sowie deren saureadditionssalzen | |
| AT329020B (de) | Verfahren zur herstellung von halogenierten 2-aminobenzylaminen sowie deren saureadditionssalzen | |
| AT340894B (de) | Verfahren zur herstellung von neuen p-nitro-acylophenon-o- (2-aminoathyl) -oximather und deren saureadditionssalzen | |
| AT339878B (de) | Verfahren zur herstellung von neuen alfa-tricycloalkylidenarylmethyloxyalkylaminen und deren saureadditonssalzen | |
| ATA502975A (de) | Verfahren zur herstellung von neuen aminobenzylaminen sowie deren saureadditionssalzen | |
| AT342021B (de) | Verfahren zur herstellung von neuen p-methylsulfinyl-acylophenon-o- (2-aminoathyl)-oximathern und deren saureadditionssalzen | |
| AT348979B (de) | Verfahren zur herstellung von neuen 7-aminomethylbenzocycloheptenen und deren saeureadditonssalzen | |
| AT327876B (de) | Verfahren zur herstellung von halogenierten 2-amino-benzylaminen sowie deren saureadditionssalzen | |
| ATA696676A (de) | Verfahren zur herstellung von neuen alfa-tricycloheptyliden-arylmethoxyalkylaminen sowie deren saureadditionssalzen | |
| AT353271B (de) | Verfahren zur herstellung von neuen 2- piperidinoalkyl-(1-benzofuranen, 1,4-benzo- dioxanen oder 1,4-benzoxathianen) und deren saeureadditonssalzen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ELJ | Ceased due to non-payment of the annual fee |